esreboxetine

esreboxetine · Axsome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for esreboxetine, covering 2011-04-07 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design [Phase 3]